CD8A and COVID-19: In agreement with previous studies (Flament et al., 2021; Parrot et al., 2020), our study identified that the proportion of circulating CD8+CD161+Vα7.2+ MAITs was significantly lower in acute as compared with late convalescent phase of COVID-19.